Aldebaran Financial’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-987
| Closed | -$242K | – | 88 |
|
|
2021
Q2 | $242K | Buy |
987
+3
| +0.3% | +$738 | 0.2% | 78 |
|
|
2021
Q1 | $245K | Buy |
984
+3
| +0.3% | +$716 | 0.22% | 75 |
|
|
2020
Q4 | $226K | Buy |
981
+3
| +0.3% | +$692 | 0.21% | 76 |
|
|
2020
Q3 | $249K | Buy |
978
+6
| +0.6% | +$1.49K | 0.26% | 70 |
|
|
2020
Q2 | $229K | Sell |
972
-3,297
| -77% | -$752K | 0.27% | 74 |
|
|
2020
Q1 | $866K | Buy |
4,269
+3
| +0.1% | +$655 | 0.85% | 39 |
|
|
2019
Q4 | $1.03M | Sell |
4,266
-2,148
| -33% | -$473K | 0.78% | 48 |
|
|
2019
Q3 | $1.24M | Buy |
6,414
+2
| +0% | +$384 | 0.83% | 49 |
|
|
2019
Q2 | $1.18M | Buy |
6,412
+3
| +0% | +$537 | 0.82% | 48 |
|
|
2019
Q1 | $1.22M | Buy |
6,409
+3
| +0% | +$573 | 0.86% | 45 |
|
|
2018
Q4 | $1.25M | Buy |
6,406
+3
| +0% | +$585 | 0.95% | 37 |
|
|
2018
Q3 | $1.33M | Buy |
6,403
+2
| +0% | +$394 | 0.86% | 43 |
|
|
2018
Q2 | $1.18M | Sell |
6,401
-1,298
| -17% | -$230K | 0.81% | 46 |
|
|
2018
Q1 | $1.31M | Buy |
7,699
+3
| +0% | +$551 | 0.88% | 46 |
|
|
2017
Q4 | $1.34M | Sell |
7,696
-198
| -3% | -$35K | 0.89% | 44 |
|
|
2017
Q3 | $1.47M | Buy |
7,894
+2
| +0% | +$354 | 1.02% | 39 |
|
|
2017
Q2 | $1.36M | Sell |
7,892
-498
| -6% | -$81K | 0.99% | 38 |
|
|
2017
Q1 | $1.38M | Buy |
8,390
+88
| +1% | +$14.6K | 1.05% | 36 |
|
|
2016
Q4 | $1.21M | Buy |
8,302
+129
| +2% | +$19.4K | 0.96% | 39 |
|
|
2016
Q3 | $1.36M | Buy |
8,173
+2
| +0% | +$338 | 1.08% | 36 |
|
|
2016
Q2 | $1.31M | Buy |
8,171
+2
| +0% | +$311 | 1.06% | 35 |
|
|
2016
Q1 | $1.23M | Buy |
8,169
+2
| +0% | +$297 | 1.07% | 34 |
|
|
2015
Q4 | $1.29M | Buy |
8,167
+402
| +5% | +$63.2K | 1.2% | 32 |
|
|
2015
Q3 | $1.07M | Sell |
7,765
-398
| -5% | -$62.7K | 1.01% | 34 |
|
|
2015
Q2 | $1.25M | Buy |
8,163
+1
| +0% | +$160 | 1.06% | 36 |
|
|
2015
Q1 | $1.3M | Buy |
8,162
+1,052
| +15% | +$166K | 1.12% | 33 |
|
|
2014
Q4 | $1.13M | Sell |
7,110
-599
| -8% | -$93.3K | 1% | 37 |
|
|
2014
Q3 | $1.08M | Buy |
7,709
+1
| +0% | +$131 | 0.97% | 37 |
|
|
2014
Q2 | $912K | Buy |
7,708
+402
| +6% | +$46.5K | 0.72% | 52 |
|
|
2014
Q1 | $901K | Sell |
7,306
-898
| -11% | -$109K | 0.79% | 46 |
|
|
2013
Q4 | $936K | Buy |
+8,204
| New | +$933K | 0.89% | 37 |
|
Other funds holding AMGN
Aldebaran Financial's AMGN Position: Q3 2021 in Review
Aldebaran Financial sold out of Amgen (AMGN) in Q3 2021, closing a stake of 987 shares — an estimated $242K sold.
Aldebaran Financial first reported a position in AMGN in Q4 2013 and held it in 31 quarters. The position peaked at $1.47M in Q3 2017. 2,131 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.
- Aldebaran Financial reported no remaining Amgen position as of Q3 2021 after selling out during the quarter.
- Aldebaran Financial sold 987 Amgen shares in Q3 2021, an estimated $242K.
- Aldebaran Financial first reported a position in Amgen in Q4 2013 and held it in 31 quarters.
- Aldebaran Financial's Amgen position peaked at $1.47M in Q3 2017.
- 2,131 funds tracked by Wall St. Rank held Amgen as of Q3 2021.
Based on Aldebaran Financial's 13F filing for Q3 2021, filed 21 Oct 2021.